Portal de investigación
Phase II trial of palbociclib in advanced sarcoma overexpressing CDK4 gene excluding dedifferentiated liposarcoma (DD LPS): A study from the Spanish Group for Research on Sarcoma (GEIS).
Fecha de publicación:
Autores de IIS La Fe
Participantes ajenos a IIS La Fe
- Broto, Javier Martin
- Garcia, Jeronimo Martinez
- Moura, David Silva
- Redondo, Andres
- Lopez-Pousa, Antonio
- Martinez-Trufero, Javier
- Sevilla, Isabel
- Solis-Hernandez, Maria Pilar
- Carnero, Amancio
- Perez, Marco
- Marcilla, David
- Lopez-Martin, Jose A.
- Herraez, Antonio Casado
- Alvarez, Rosa Maria Alvarez
- Jurado, Josefina Cruz
- Estival-Gonzalez, Anna
- Ledesma, Patricio
- Hindi, Nadia
Grupos
Abstract
Abstract no disponible
Filiaciones
Filiaciones no disponibles
Campos de Estudio
Cita
Broto,JM,Garcia,JM,Moura,DS,Redondo,A,Gutierrez,A,Lopez,A,Martinez,J et al. Phase II trial of palbociclib in advanced sarcoma overexpressing CDK4 gene excluding dedifferentiated liposarcoma (DD LPS): A study from the Spanish Group for Research on Sarcoma (GEIS). Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO). 2022. ELECTR NETWORK-JUN 03-07. TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103:LIPPINCOTT WILLIAMS & WILKINS. 2022.